Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSupply@me Cap Regulatory News (SYME)

Share Price Information for Supply@me Cap (SYME)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.0284
Bid: 0.03
Ask: 0.031
Change: 0.0029 (11.37%)
Spread: 0.001 (3.333%)
Open: 0.025
High: 0.04
Low: 0.025
Prev. Close: 0.0255
SYME Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

New Loan Facility closes Agreement with Negma

2 Sep 2021 07:00

RNS Number : 5182K
Supply @ME Capital PLC
02 September 2021
 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS STIPULATED UNDER THE UK VERSION OF THE MARKET ABUSE REGULATION NO 596/2014 WHICH IS PART OF ENGLISH LAW BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018, AS AMENDED. ON PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INFORMATION IS CONSIDERED TO BE IN THE PUBLIC DOMAIN.

 

02 September 2021

 

Supply@ME Capital plc

(The "Company" or "SYME")

Supply@ME agrees new short-term loan facility to close Agreement with Negma Group

 

Supply@ME Capital plc, the innovative fintech platform which provides an Inventory Monetisation© service to manufacturing and trading companies, is pleased to announce it has signed a term sheet for a short-term loan facility with a family office investor, provided by ARC Group[1] ("ARC").

ARC Group is a global Investment Bank specialising in the middle markets, with representative offices across all continents. The Bank focuses on providing global fundraising solutions to its clients from institutional investors.

Subject to the execution of the definitive agreement, the short-term loan facility will replace the Subscription Agreement previously signed with Negma Group Ltd ("Negma Group"), as per the RNS of 16 June 2021. In relation to the Negma Group facility, the Company has made an application to the London Stock Exchange and the Financial Conduct Authority for admission to trading of 840,000,000 New Ordinary Shares (representing less than 3% of the Company's issued share capital) to be allotted to Negma Group. The remaining outstanding par value of the Convertible Loan Notes not yet converted is £2,106,000 and this residual portion is expected to be repaid in cash, funded by the new short-term loan facility.

Pursuant to the current contract executed with the Company, Negma Group:

- will not undertake any short sales of the Company's Ordinary Shares or any lending of the Company's Ordinary Shares;

- with respect to any disposal of Ordinary Shares on any given day, will not participate in more than twenty five percent (25%) of the daily Value Traded with respect to the Ordinary Shares on such day.

Loan conditions

The new agreement with the family office provided by ARC will help to ensure that the Company continues to be well capitalised and increases its balance sheet flexibility enabling its growth initiatives.

SYME has agreed to the following key terms for the facility:

· Initial tranche of £5 million, with a further £2 million available within 60 days;

· 12-month term, with an interest rate of 10%;

· Warrants will be issued for 20% of the £7 million loan value. The warrants will have a term of 3 years and exercise price of 130% of the lowest closing VWAP over the ten days immediately preceding the issue of the loan.

 

The ARC short-term loan facility will be linked to a Convertible Loan Note facility (CLN), should the Company require cash to facilitate further growth and need to trigger the facility.

 

At the same time SYME will work closely with ARC to further explore a dual listing on NASDAQ. In this regard, SYME will benefit from ARC's expertise in supporting foreign issuers on their journey onto NASDAQ and post-listing.

 

Alessandro Zamboni, CEO, Supply@ME Capital plc, said: "This is a key development for Supply@ME providing us with further flexibility to execute our plans and accelerate our expansion in key markets. ARC was impressed with our recent developments, confirmed by the recent trading update and the related revenue guidance. I am very pleased to strengthen our relationship with ARC at this important stage in our company's growth and I look forward to working with them closely as we further our efforts towards a dual listing. I would like to thank the Negma Group for the support provided which has enabled us to acquire TradeFlow and to support our recent growth initiatives as we move towards securing our first inventory monetisation transactions."

 

Jesús Emilio Hoyos, Managing Partner of ARC Group, said: "As the Financial Advisor to Supply@ME, we are very excited to facilitate this partnership between the Company and this Family Office. We believe that this is the beginning of great journey together and that the funds will help support the future growth of the Company."

 

Notes

The Company enables businesses to generate cashflow, via a non-credit approach and without incurring debt, by monetising their existing stock which is intended to be sold to end-customers or through monetisation of goods and or commodities as part of a typical import/ export transaction. SYME' Global Inventory Monetisation Fund enables creditworthy companies to improve their working capital cycle. The Fund does not target monetisation of inventories owned by companies in financial distress or otherwise seeking to monetise illiquid inventories.

 

Contacts

Alessandro Zamboni, CEO, Supply@ME Capital plc, investors@supplymecapital.com

Paul Vann, Walbrook PR Limited, +44 (0)20 7933 8780; paul.vann@walbrookpr.com

Brian Norris, Cicero/AMO, +44 (0)20 7947 5317 brian.norris@cicero-group.com

 

 

[1] https://www.arccap.us/

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFZGGLKZVGMZG
Date   Source Headline
29th Apr 202412:27 pmRNSAgreement signed to launch a IM programme
5th Apr 20247:00 amRNSBusiness update
4th Apr 20247:00 amRNSDirector/PDMR Shareholding
28th Mar 20247:00 amRNSTransfer of Warrants
27th Mar 20247:00 amRNSTransaction of a Person Closely Associated
22nd Mar 20247:00 amRNSPDMR/PCA shareholding: stock loans update
29th Feb 20247:00 amRNSBusiness, trading and funding update
19th Feb 20247:00 amRNSExercise of warrants, issue of equity and TVR
26th Jan 20247:00 amRNSHolding(s) in Company
11th Jan 20247:00 amRNSExercise of warrants, issue of equity and TVR
3rd Jan 20247:00 amRNSWhite-Label IM Agreement - funding secured
5th Dec 20238:40 amRNSFunding and Business update
23rd Nov 20237:00 amRNSTransfer of Warrants
6th Nov 20237:00 amRNSExercise of Warrants, issue of equity and TVR
1st Nov 20238:58 amRNSTotal Voting Rights
10th Oct 20237:00 amRNSExercise of Warrants, issue of equity and TVR
29th Sep 20237:00 amRNSHalf-year Report
25th Sep 20237:00 amRNSExercise of Warrants, issue of equity and TVR
12th Sep 20237:00 amRNSExercise of Open Offer Warrants
1st Sep 20237:00 amRNSTotal Voting Rights
17th Aug 20237:00 amRNSExercise of options, issue of equity and TVR
4th Aug 202312:34 pmRNSHolding(s) in Company
2nd Aug 20237:00 amRNSTotal Voting Rights
7th Jul 20237:00 amRNSDirector/PDMR Shareholding
5th Jul 20237:00 amRNSExercise of Warrants, issue of equity and TVR
3rd Jul 20237:00 amRNSExecution of first UK IM using traditional funding
30th Jun 20235:36 pmRNSHolding(s) in Company
30th Jun 202312:54 pmRNSTotal Voting Rights
30th Jun 20237:00 amRNSTransaction of a Person Closely Associated
23rd Jun 20235:37 pmRNSResult of General Meeting
23rd Jun 20235:36 pmRNSResult of AGM
15th Jun 202311:00 amRNSReplacement Total Voting Rights
15th Jun 20238:00 amRNSNew Italian PNP regulation comes into effect
13th Jun 20237:00 amRNSExercise of Warrants, issue of equity and TVR
9th Jun 20237:00 amRNSFirst UK IM transaction from traditional funding
5th Jun 20237:00 amRNSExercise of Warrants, Issue of Equity and TVR
2nd Jun 202312:51 pmRNSHolding in Company
31st May 20233:56 pmRNSNotice of GM of Open Offer Warrantholders
31st May 20233:55 pmRNSNotice of Annual General Meeting
26th May 20237:00 amRNSAdmission of Shares and Total Voting Rights
23rd May 20237:00 amRNSExercise of Warrants, Issue of Equity and TVR
22nd May 20237:00 amRNSGrant of Awards under the Supply@ME LTIP
19th May 20231:40 pmRNSHolding(s) in Company
16th May 20237:00 amRNSInvestor Presentation via Investor Meet Company
9th May 20233:03 pmRNSHolding(s) in Company
5th May 20237:00 amRNSExecution of first IM from traditional funding
4th May 202312:40 pmRNSAdmission and Exercise of Open Offer Warrants
2nd May 202312:00 pmRNSSYME moves to SETS trading platform
28th Apr 20232:51 pmRNS2022 Annual Report and Accounts and Financing
26th Apr 20237:00 amRNSCommitment for first IM from traditional funding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.